Gene expression profiling in MDS and AML: potential and future avenues.

Gene expression profiling in MDS and AML: potential and future avenues.

Today, the classification systems for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) already incorporate cytogenetic and molecular genetic aberrations in an attempt to better reflect disease biology. However, in many MDS/AML patients no genetic aberrations have been identified yet,...

Full description

Bibliographic Details
Main Authors:	Theilgaard-Mönch, K, Boultwood, J, Ferrari, S, Giannopoulos, K, Hernandez-Rivas, J, Kohlmann, A, Morgan, M, Porse, B, Tagliafico, E, Zwaan, C, Wainscoat, J, Van den Heuvel-Eibrink, MM, Mills, K, Bullinger, L
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
by: Goh, Chermaine Yu Zhen
Published: (2021)

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial.
by: Hoyle, C, et al.
Published: (1989)

Telomere length is an independent prognostic marker in MDS but not in de novo AML
by: Williams, J, et al.
Published: (2017)

Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.
by: Barreyro, L, et al.
Published: (2012)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
by: Peniket, A, et al.
Published: (1999)

Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency
by: Hasemann, MS, et al.
Published: (2012)

The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.
by: Nilsson, L, et al.
Published: (2007)

Molecular characterization of the chromosome 9q deletion in AML.
by: Side, L, et al.
Published: (2000)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH)
by: Esoof, N, et al.
Published: (2005)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
by: Peniket, A, et al.
Published: (2005)

Physical and transcriptional characterization of the commonly deleted region in del(9q) AML.
by: Daly, S, et al.
Published: (2001)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
by: Esoof, N, et al.
Published: (2006)

Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
by: Porse, B, et al.
Published: (2005)

Alternative avenue.
by: Chan, Guang Hui.
Published: (2012)

Generalized GM-MDS: Polynomial Codes Are Higher Order MDS
by: Brakensiek, Joshua, et al.
Published: (2024)

MDS plus data acquisition system
by: Stillerman, J.A., et al.
Published: (2015)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
by: Jadersten, M, et al.
Published: (2005)

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
by: Stahl, M, et al.
Published: (2023)

The weights in MDS codes
by: Ezerman, Martianus Frederic, et al.
Published: (2019)

Identification of candidate tumor suppressor genes in the commonly deleted region of del(9q) AML.
by: Sweetser, D, et al.
Published: (2002)

NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements.
by: Weischenfeldt, J, et al.
Published: (2008)

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
by: Efficace, F, et al.
Published: (2024)

Identification of two distinct pathways of human myelopoiesis
by: Drissen, R, et al.
Published: (2019)

Recent advances in MDS mutation landscape: splicing and signalling
by: Follo, MY, et al.
Published: (2019)

Western Avenue Extension/
Published: (1968)

Application of classical Hermitian self-orthogonal MDS codes to quantum MDS codes
by: Jin, Lingfei, et al.
Published: (2012)

Downregulation of Ribosomal Proteins Is Seen in Non 5q-MDS
by: Sohal, P, et al.
Published: (2008)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
by: Pellagati, A, et al.
Published: (2008)

MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS)
by: Chen, J, et al.
Published: (2022)

A novel gene is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood AML.
by: Jaju, R, et al.
Published: (2000)

New quantum MDS codes
by: Zhang, Guanghui, et al.
Published: (2015)

The architecture of St Charles Avenue /
by: 379695 Kirk, Susan Lauxman, et al.
Published: (1977)

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.
by: Zhou, L, et al.
Published: (2008)

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
by: Malcovati, L, et al.
Published: (2020)

MicroRNA epigenetics: a new avenue for wound healing research.
by: Bavan, L, et al.
Published: (2011)

Diffusion analysis of EFN-MDS structure
by: Ibrahim, Subariah
Published: (2006)

Diffusion analysis of EFN-MDS structure
by: Ibrahim, Subariah, et al.
Published: (2006)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics
by: Fernandez-Mercado, M, et al.
Published: (2012)

A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood AML.
by: Jaju, R, et al.
Published: (1998)

Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.
by: Hasemann, MS, et al.
Published: (2008)